Trump tariff shock spreads to U.S. IPO market as several companies' plans to go public change
Golden Finance reports that a glimmer of hope for an imminent recovery in U.S. IPOs has vanished, according to the Wall Street Journal. Ticketing marketplace StubHub and fintech firm Klarna have postponed their IPO roadshows, which were scheduled to begin next week, according to people familiar with the matter. Chime, another fintech company that is delaying the filing of public financial reports with regulators, has also postponed its IPO, some of those people said. virtual physical therapy company Hinge Health is eyeing the market and expects to go public by the end of April, people familiar with the matter said. Cryptocurrency company Circle is close to the next step of going public, but is now anxiously watching before deciding what to do. In addition, there are reports that Medline, a medical technology company, is delaying its U.S. IPO. the stock market crash on Thursday and Friday closed the door on companies waiting to go public. The U.S. IPO market has gone through a rough patch over the past three years, but many bankers and lawyers were hopeful that 2025 would be the year IPOs returned to their normal pace. Instead, a global trade war is roiling the stock market, rattling investors and executives alike.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SQM.US Q3 profit misses expectations; lithium price declines but demand outlook remains “encouraging”
SQM.US still reports seeing "encouraging" potential demand trends.
Mizuho: Consecutive system outages in the US trigger stockpiling surge! With short-term demand boosted, Costco (COST.US) sales momentum is expected to remain strong.
According to a report by Mizuho Securities analysts, following a series of recent system failures in the United States, consumers have started stockpiling essential goods, leading to a short-term surge in demand for Costco, a members-only retailer.

Biogen (BIIB.US) announces mid-stage trial data for early Alzheimer's candidate drug diranersen: significant slowing of clinical decline over two years
Biogen has released the latest interim clinical trial data for its early-stage Alzheimer's disease candidate drug, diranersen.

Nvidia Acting CEO Kress Reassures the Market: No Customer Loss and No Employee Exodus
Nvidia released its first quarterly financial report since Jensen Huang's resignation, after which Colette Kress told the media that major client demand has not been affected and the workforce remains stable, emphasizing that "everything is business as usual." The company's share price rose over 3% after hours, though the stock is still down 24% for the month.